These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 26771848)

  • 21. Genomic profile of human meningioma cell lines.
    Mei Y; Bi WL; Greenwald NF; Agar NY; Beroukhim R; Dunn GP; Dunn IF
    PLoS One; 2017; 12(5):e0178322. PubMed ID: 28552950
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic landscape of meningioma.
    Yuzawa S; Nishihara H; Tanaka S
    Brain Tumor Pathol; 2016 Oct; 33(4):237-247. PubMed ID: 27624470
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A high-throughput kinome screen reveals serum/glucocorticoid-regulated kinase 1 as a therapeutic target for NF2-deficient meningiomas.
    Beauchamp RL; James MF; DeSouza PA; Wagh V; Zhao WN; Jordan JT; Stemmer-Rachamimov A; Plotkin SR; Gusella JF; Haggarty SJ; Ramesh V
    Oncotarget; 2015 Jul; 6(19):16981-97. PubMed ID: 26219339
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Meningiomas and neurofibromatosis for the oncologist.
    Schrell UM; Fahlbusch R; Adams EF
    Curr Opin Oncol; 1994 May; 6(3):247-53. PubMed ID: 8080853
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular genetics of meningiomas.
    Youngblood MW; Günel M
    Handb Clin Neurol; 2020; 169():101-119. PubMed ID: 32553282
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Meningioma: current updates on genetics, classification, and mouse modeling.
    Szulzewsky F; Thirimanne HN; Holland EC
    Ups J Med Sci; 2024; 129():. PubMed ID: 38571886
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Meningioma: an update.
    Lusis E; Gutmann DH
    Curr Opin Neurol; 2004 Dec; 17(6):687-92. PubMed ID: 15542977
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathological classification and molecular genetics of meningiomas.
    Mawrin C; Perry A
    J Neurooncol; 2010 Sep; 99(3):379-91. PubMed ID: 20809251
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genomic analysis of spinal meningiomas: correlation with histopathological grade.
    Driver J; Santagata S; Bi WL; Chi JH
    J Neurosurg Spine; 2023 Dec; 39(6):729-733. PubMed ID: 37728381
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exome sequencing on malignant meningiomas identified mutations in neurofibromatosis type 2 (NF2) and meningioma 1 (MN1) genes.
    Zhang X; Jia H; Lu Y; Dong C; Hou J; Wang Z; Wang F; Zhong H; Wang L; Wang K
    Discov Med; 2014 Dec; 18(101):301-311. PubMed ID: 25549701
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular genetics of meningiomas: Building the roadmap towards personalized therapy.
    Peyre M; Kalamarides M
    Neurochirurgie; 2018 Mar; 64(1):22-28. PubMed ID: 25245924
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Molecular and Immunological Landscape of Meningiomas.
    Lotsch C; Warta R; Herold-Mende C
    Int J Mol Sci; 2024 Sep; 25(17):. PubMed ID: 39273576
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Meningiomas: new prognostic factors].
    Sanz Esponera J
    An R Acad Nac Med (Madr); 2007; 124(2):319-32; discussion 330-2. PubMed ID: 18069599
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genomic Landscape of Meningiomas.
    Wang JZ; Nassiri F; Mawrin C; Zadeh G
    Adv Exp Med Biol; 2023; 1416():137-158. PubMed ID: 37432625
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Meningiomas: Overview and New Directions in Therapy.
    Wang N; Osswald M
    Semin Neurol; 2018 Feb; 38(1):112-120. PubMed ID: 29548058
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oncogenic PI3K mutations are as common as AKT1 and SMO mutations in meningioma.
    Abedalthagafi M; Bi WL; Aizer AA; Merrill PH; Brewster R; Agarwalla PK; Listewnik ML; Dias-Santagata D; Thorner AR; Van Hummelen P; Brastianos PK; Reardon DA; Wen PY; Al-Mefty O; Ramkissoon SH; Folkerth RD; Ligon KL; Ligon AH; Alexander BM; Dunn IF; Beroukhim R; Santagata S
    Neuro Oncol; 2016 May; 18(5):649-55. PubMed ID: 26826201
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clear cell meningiomas: three case reports with genetic characterization and review of the literature.
    Ohba S; Sasaki H; Kimura T; Ikeda E; Kawase T
    Neurosurgery; 2010 Sep; 67(3):E870-1; discussion E871. PubMed ID: 20683214
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular genetics of meningiomas: a systematic review of the current literature and potential basis for future treatment paradigms.
    Pham MH; Zada G; Mosich GM; Chen TC; Giannotta SL; Wang K; Mack WJ
    Neurosurg Focus; 2011 May; 30(5):E7. PubMed ID: 21529178
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current standing and frontiers of gene therapy for meningiomas.
    De La Garza-Ramos R; Flores-Rodríguez JV; Martínez-Gutiérrez JC; Ruiz-Valls A; Caro-Osorio E
    Neurosurg Focus; 2013 Dec; 35(6):E4. PubMed ID: 24289129
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genomic analysis of non-neurofibromatosis type 2 meningiomas.
    Parry PV; Engh JA
    Neurosurgery; 2013 Jun; 72(6):N18-9. PubMed ID: 23685513
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.